Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus InfectionThe FRAM Study
Open Access
- 12 November 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (20) , 2213-2219
- https://doi.org/10.1001/archinte.167.20.2213
Abstract
Kidney disease has been identified as an important complication of human immunodeficiency virus (HIV) infection.1 Investigators have noted the increasing prevalence of HIV in the population with end-stage renal disease, as well as the high prevalence of kidney disease in persons with HIV.2-5 This high prevalence may be owing to the longer life expectancy in the highly active antiretroviral therapy era. Whether HIV infection has a direct effect on kidney function is not known. In addition, there is substantial evidence that HIV infection is independently associated with many risk factors for kidney disease, such as adverse changes in lipid levels,6,7 increased insulin resistance,8,9 and microalbuminuria.10 Taken together, these factors illustrate the need for a population-based study of kidney function in HIV-infected individuals and healthy controls.This publication has 35 references indexed in Scilit:
- Microalbuminuria in HIV infectionAIDS, 2007
- Cystatin C and Measures of Physical Function in Elderly Adults: The Health, Aging, and Body Composition (HABC) StudyAmerican Journal of Epidemiology, 2006
- The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): Methods, Design, and Sample CharacteristicsAmerican Journal of Epidemiology, 2006
- Cystatin C and Mortality Risk in the ElderlyJournal of the American Society of Nephrology, 2006
- Heroin-associated nephropathyExpert Opinion on Drug Safety, 2005
- Is There an Epidemic of HIV Infection in the US ESRD Program?Journal of the American Society of Nephrology, 2004
- Plasma cystatin C as a marker of renal function in patients with liver cirrhosisScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Cystatin C: Efficacy as Screening Test for Reduced Glomerular Filtration RateAmerican Journal of Nephrology, 2000
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999